Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

201.

Pulmonary embolism.

Lancet.
Goldhaber SZ.
| Apr 17, 2004
202.

Alcohol intake and risk of incident gout in men: a prospective study.

Lancet.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G.
| Apr 17, 2004
203.

HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.

Lancet.
Hess C, Altfeld M, Thomas SY, Addo MM, Rosenberg ES, Allen TM, Draenert R, Eldrige RL, van Lunzen J, Stellbrink HJ, Walker BD, Luster AD.
| Mar 13, 2004
204.

Programmes and principles in treatment of multidrug-resistant tuberculosis.

Lancet.
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ.
| Feb 7, 2004
206.

A tale of two viruses: hepatitis C in the age of HAART.

Lancet.
Alatrakchi N, Koziel MJ.
| Nov 22, 2003
207.

Adiponectin: linking the fat cell to insulin sensitivity.

Lancet.
Goldfine AB, Kahn CR.
| Nov 1, 2003
208.

Small RNA: can RNA interference be exploited for therapy?

Lancet.
Wall NR, Shi Y.
| Oct 25, 2003
209.

HIV-1 care in resource-poor settings: a view from Haiti.

Lancet.
Mukherjee JS.
| Sep 20, 2003
210.

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Lancet.
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S.
| Sep 6, 2003
211.

Improving antithrombotic treatment in patients after myocardial infarction.

Lancet.
Giugliano RP, Braunwald E.
| Sep 6, 2003
212.

Liver donation: donor safety comes first.

Lancet.
Surman OS, Hertl M.
| Aug 30, 2003
213.

Clinical xenotransplantion--how close are we?

Lancet.
Cooper DK.
| Aug 16, 2003
214.

Human genetic variation and disease.

Lancet.
Meyerson M.
| Jul 26, 2003
215.

Using "rationally designed drugs" rationally.

Lancet.
Brugarolas J, Clark JW, Chabner B.
| May 24, 2003
216.

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

Lancet.
Nisbet-Brown E, Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Séchaud R, Krebs-Brown AJ, Anderson JR, Alberti D, Sizer KC, Nathan DG.
| May 10, 2003
217.

DNA microarrays in breast cancer: the promise of personalised medicine.

Lancet.
Ramaswamy S, Perou CM.
| May 10, 2003
218.

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Lancet.
Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X, Mavros C, Coccia JA, Faget KY, Fitch KA, Masters CL, Tanzi RE, Chylack LT, Bush AI.
| Apr 12, 2003
219.

Uses of error: Surgical mistakes.

Lancet.
Hettiaratchy S.
| Sep 15, 2001
220.

Bone marrow transplantation for the heart: fact or fiction?

Lancet.
Laham RJ, Oettgen P.
| Jan 4, 2003